Last reviewed · How we verify
steroids, monoclonal anti-IL2R antibody
steroids, monoclonal anti-IL2R antibody is a Small molecule drug developed by Astellas Pharma Inc. It is currently in Phase 2 development.
At a glance
| Generic name | steroids, monoclonal anti-IL2R antibody |
|---|---|
| Sponsor | Astellas Pharma Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation (PHASE3)
- CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment (PHASE3)
- Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts (PHASE3)
- Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation. (PHASE3)
- Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX (PHASE2)
- Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients (PHASE2)
- Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- steroids, monoclonal anti-IL2R antibody CI brief — competitive landscape report
- steroids, monoclonal anti-IL2R antibody updates RSS · CI watch RSS
- Astellas Pharma Inc portfolio CI
Frequently asked questions about steroids, monoclonal anti-IL2R antibody
What is steroids, monoclonal anti-IL2R antibody?
steroids, monoclonal anti-IL2R antibody is a Small molecule drug developed by Astellas Pharma Inc.
Who makes steroids, monoclonal anti-IL2R antibody?
steroids, monoclonal anti-IL2R antibody is developed by Astellas Pharma Inc (see full Astellas Pharma Inc pipeline at /company/astellas).
What development phase is steroids, monoclonal anti-IL2R antibody in?
steroids, monoclonal anti-IL2R antibody is in Phase 2.